|
Anti-Aging of Our Optic Nerve-Dream or Reality?
|
Abstract:
This paper presents findings on the potential of combining Selective Laser Trabeculoplasty (SLT) with Resveratrol supplementation to treat optic nerve degeneration in glaucoma patients. Glaucoma is a multifactorial disease where IOP-lowering therapies often fail to halt progression, especially in low-tension glaucoma cases. SLT activates macrophages, promoting cleaning of the trabecular meshwork, while Resveratrol enhances mitochondrial function, reduces oxidative stress, and supports optic nerve regeneration. Our results from over 12,000 patients show that this integrative approach improves optic nerve health, particularly in patients with normal IOP.
[1] | Weinreb, R. (2016) Glaucoma Progression Despite IOP Lowering: Causes and Therapeutic Strategies. Ophthalmology, 123, 198-202. |
[2] | Campbell, K., et al. (2014) ATP Homeostasis in Axonal Survival: Implications for Neurodegenerative Diseases. Journal of Neuroscience, 34, 2458-2465. |
[3] | Lee, J. and Yu, K. (2023) SIRT1 and Autophagy in Optic Nerve Protection. Journal of Neuro-Ophthalmology, 42, 315-320. |